GRD Biotechnology Acquisition ^{Filed Terms, Nasdaq: CGRD}

We are a newly organized blank check company. While we may pursue an initial business combination target in any stage of its corporate evolution of in any industry, sector or geographic location (subject to certain limitations described in this prospectus), we intend to focus our search in the Asian biotechnology sector. We intend to source initial business combination opportunities through our management team’s extensive network of biotechnology sector business owners, public and private company executives and board members, investment bankers, private equity and debt investors, high net worth families and their advisors, commercial bankers, attorneys, management consultants, accountants and other transaction intermediaries. We believe this approach, as well as our management team’s recognized track record of completing acquisitions across a variety of subsectors within the biotechnology sector will provide meaningful opportunities to drive value creation for shareholders.